Trials / Unknown
UnknownNCT03804723
Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus
Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus: a Randomized Placebo-controlled Equivalence Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 321 (estimated)
- Sponsor
- University of Pisa · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is a 36 months, randomized, double-blind, placebo-controlled, parallel-groups, equivalence multicenter trial in patients with inactive Systemic Lupus Erythematosus to evaluate if low disease activity can be sustained with withdrawal of glucocorticoids in patients on stable clinical remission or low disease activity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | oral Prednisone 5mg | patients randomized to this arm will stop prednisone 5 mg |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2022-06-01
- Completion
- 2023-09-01
- First posted
- 2019-01-15
- Last updated
- 2019-01-18
Source: ClinicalTrials.gov record NCT03804723. Inclusion in this directory is not an endorsement.